Brevan Howard Capital Management LP Charles River Laboratories International, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 11,197 shares of CRL stock, worth $1.88 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,197
Previous 33,544
66.62%
Holding current value
$1.88 Million
Previous $5.09 Million
65.59%
% of portfolio
0.01%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
642Shares Held
51.6MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...